↑ parent activity group ·
research dossier →

FIELD TO HEALED FOUNDATION
Phoenix, AZ · EIN 822455297 · Form 990EZ · FY2022 · NTEE E01 · Health Care · Small ($100K-$1M) · fieldtohealed.love
revenue
$122K
expenses
$102K
net assets
$37K
employees
—
mission · from form 990

Scientific

profile · synthesized from sources

Conducts clinical research on Schedule I plant and fungal medicines, including cannabis and psilocybin, for treatment-resistant conditions. Focuses on veterans and underserved populations through FDA-authorized trials, public policy engagement, and access programs like Right to Try. Operates as one of the few U.S. facilities with federal licensing to cultivate and study these substances.

named programs · 2 · from sources

what they call their work

Cannabis and Psilocybin Clinical Trials
FDA-authorized clinical trials investigating the therapeutic potential of whole plant and fungal medicines for treatment-resistant conditions
Right to Try Program
Provides access to investigational plant and fungal medicines for patients with life-threatening conditions under federal Right to Try legislation
activities · 1 group

what they do

  • Psychedelic and Consciousness Clinical Research 7 activities
    • Clinical Research on Plant and Fungal Medicines
      Conducts federally licensed, nonprofit clinical research on whole plant and fungal medicines, including Schedule I substances, for FDA-authorized clinical trials.
    • Clinical research on whole plant and fungal medicines
      Conducts ethical, federally authorized clinical research on whole plant and fungal medicines, including Schedule I substances, to evaluate their therapeutic potential. Operates under DEA licensure for cultivation, manufacturing, and study within FDA-authorized clinical trials.
    • Clinical research on whole plant and fungal medicines
      Conducts ethical, federally authorized clinical research on whole plant and fungal medicines, operating under federal licensure and focusing on substances classified as Schedule I.
    • Clinical research on whole plant and fungal medicines
      Conducts ethical, federally authorized clinical research on whole plant and fungal medicines, including Schedule I substances, to evaluate their therapeutic potential. Operates under DEA licensure for cultivation, manufacturing, and study within FDA-authorized clinical trials.
    • LSD-Assisted Therapy Research for Anxiety
      Sponsored and conducted a pilot study on the therapeutic use of LSD for anxiety in patients with life-threatening illnesses, demonstrating significant anxiety reduction and lasting effects with no major adverse events.
    • LSD-assisted therapy study for anxiety in life-threatening illness
      Sponsored and conducted the first U.S. study in over 40 years on LSD's therapeutic use, specifically for anxiety in patients with life-threatening illnesses. The double-blind, randomized, active placebo-controlled pilot study with 12 participants showed statistically significant reduction in anxiety (p=0.021) at two months, with effects lasting up to 12 months and no significant adverse events.
    • LSD-assisted therapy study for anxiety in life-threatening illness
      Sponsored and conducted the first U.S. study on LSD's therapeutic use in humans in over 40 years, including a double-blind, randomized, active placebo-controlled pilot trial with 12 participants. Found statistically significant reduction in anxiety (p=0.021) two months post-treatment, with effects lasting at 12 months and no significant adverse events.
financials · form 990EZ · fy2022
revenue
Total revenue$122K
Contributions & grants$122K100%
Program service revenue$00%
Investment income$00%
Other revenue$0
expenses
Total expenses$102K
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits$0
Grants paid out$0
balance sheet
Total assets$37K
Cash—
Investments—
Liabilities—
Net assets$37K
1 years on record · 2022–2022
leadership · form 990 part vii · fy2022

who runs it

board members · 2
  • John Lenstrohm — Director
  • Kendric Speagle — Director